A potential new drug target for a deadly form of leukaemia
- Researcher: Professor Suzanne Cory
- Institution: The Walter and Eliza Hall Institute of Medical Research, Melbourne, Australia
- Award Amount: £249,999 for 3 years from 1st March 2019
- Cancer Type: Blood Cancer, Leukaemia
Professor Suzanne Cory based at The Walter and Eliza Hall Institute of Medical Research, Melbourne, Australia, is studying the role of MNT, an antagonist of the protein MYC, to explore its role in enabling AML cells to stay alive in the body. By unravelling the molecular connections that link MNT to cancer, they hope to discover a new target for drug development for AML.
The Research That Is Happening Right Now
Explore current projects to see how far-reaching our research is from a global perspective.
See the difference our research projects make.